CRMD
CorMedix Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +7.1% ·
share flow +12.2% ·
net new positions +6.7%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 33.01K | $241,641 | n/a | n/a |
| Q2 2026 | 82 | +2 | 27.12M | $212.84M | +4 | −4 |
| Q1 2026 | 85 | -1 | 25.38M | $172.62M | +10 | −11 |
| Q4 2025 | 85 | +1 | 28.40M | $330.32M | +1 | n/a |
| Q3 2025 | 16 | -2 | 20.70M | $240.74M | +1 | −3 |
| Q2 2025 | 15 | +1 | 18.26M | $224.97M | +2 | −1 |
| Q1 2025 | 11 | 0 | 6.59M | $40.58M | +1 | −1 |
| Q4 2024 | 11 | +1 | 7.02M | $56.86M | +2 | −1 |
| Q3 2024 | 9 | -2 | 3.76M | $30.38M | n/a | −2 |
| Q2 2024 | 11 | n/a | 4.01M | $17.37M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 5.36M | n/a | $66.03M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passive) | 4.33M | n/a | $53.29M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Marshall Wace ✦ | 2.58M | +1019.2% | $31.79M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 4 | Citadel Advisors ✦ | 1.71M | +1517.6% | $21.12M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 1.60M | +4.1% | $19.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 1.60M | +11.4% | $19.67M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 316.96K | +1034.0% | $3.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 219.80K | -4.7% | $2.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 171.12K | +4.4% | $2.11M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 10 | Renaissance Technologies ✦ | 152.20K | New | $1.88M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 98.67K | +582.0% | $1.22M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 12 | Millennium Management ✦ | 56.29K | -84.8% | $693,444 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 32.11K | +20.3% | $396,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 28.04K | New | $345,443 | 0.0% | New | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 7.78K | n/a | $95,803 | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $1.88M | 0.0% |
| Point72 Asset Management | $345,443 | 0.0% |
Exited
| Elliott Investment Management | $15.06M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 184 holders, 40.43M shares, $271.85M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.